Loading…
Science and Technology Regulatory Relief Act of 2012
Legislative Progress
Introduced
February 16, 2012
Latest Action
February 16, 2012
Primary Sponsor
Brian P. BilbrayRepublican(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2012 · third_quarter · Health Issues
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the FDA medical device regulatory system particularly to promote greater efficiency, transparency, and predictability, particularly through the 510(k) system. The following bills accomplish those goals: H.R. 3209 - Premarket Predicability Act H.R. 3203 - Novel Device Regulatory Relief Act H.R. 3230 - Keeping America Competitive through Harmonization Act H.R. 3205 - FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 - Humanitarian Device Reform Act H.R. 3208 - Patients Come First Act H.R. 3206 - Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 - Food and Drug Administration Mission Reform Act H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act H.R. 3204 - Guidance Accountability and Transparency Act H.R. 3847 - Safety of Untested and New Devices Act of 2012 H.R. 3975 - A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056 - Science and Technology Regulatory Relief Act H.R. 5651 - Food and Drug Administration Reform Act 2012 S. 1700 - The Medical Device Regulatory Improvement Act S. 1865 - The Patient Access to Medical Innovation Act S. 1943 - Novel Device Regulatory Relief Act of 2011 S. 1972 - A bill to amend the Food and Drug Administration's mission S. 1995 - A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067 - Safe, Transparent, and Efficient Medical Device Act S. 2113 - A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193 - Ensuring Safe Medical Devices for Patients S. 3187 - A bill to amend the Federal Food, Drug, and Cosetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $360,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act H.R. 5651- Food and Drug Administration Reform Act of 2012 S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients S.3187- A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Energy/Nuclear
HR 7: American Energy and Infrastructure Jobs Act of 2012; provisions related to energy HR 1230: Restarting American Offshore Leasing Now Act; provisions related to energy HR 1572: Offshore Installation Emergency Evacuation Act; provisions related to energy HR 1938: North American-Made Energy Security Act; provisions related to energy development and Keystone XL pipeline HR 2354: Energy and Water Development and Related Agencies Appropriations Act of 2012; provisions related to energy production and water projects HR 2401: Transparency in Regulatory Analysis of Impacts on the Nation (TRAIN) Act of 2011; provisions related to energy HR 2587: Protecting Jobs from Government Interference Act; provisions related to energy HR 2845: Pipeline Safety, Regulatory Certainty, and Job Creation Act of 2011; provisions related to pipeline safety HR 3221: Job Creation and Energy Efficiency Act; provisions related to energy HR 3227: To prohibit the Secretary of the Interior from issuing oil and gas leases on portions of the Outer Continental Shelf located off the coast of New Jersey; provisions related to energy HR 3229: Fuel Loss Abatement and Royalty Enhancement (FLARE) Act; provisions related to energy HR 3235: Education and Energy Act of 2011; provisions related to energy HR 3407: Alaskan Energy for American Jobs Act; provisions related to energy HR 3408: Protecting Investment in Oil Shale the Next Generation of Environmental, Energy, and Resource Security (PIONEERS) Act; provisions related to energy HR 3410: Energy Security and Transportation Jobs Act; provisions related to energy HR 3431: To prohibit the Administrator of the Environmental Protection Agency from granting a waiver under section 211(f)(4) of the Clean Air Act for any fuel or fuel additive that will reduce fuel efficiency or cause or contribute to engine damage; provisions related to energy HR 3441: Stop Green Initiative Abuse Act of 2011; provisions related to energy HR 3446: Fair Payment for Energy and Mineral Production on Public Lands Act; provisions related to energy HR 3537: North American Energy Security Act; provisions related to energy HR 3548; North American Energy Access Act; provisions related to energy and taxes HR 3879: To provide for streamlining the process of Federal approval for construction or expansion of petroleum refineries, and for other purposes; provisions related to energy HR 3882: Mid-Atlantic Energy and Jobs Act of 2012; provisions related to energy HR 3900: To ensure that oil transported through the Keystone XL pipeline is used to reduce United States dependence on Middle Eastern oil; provisions related to exports HR 4017: Smart Energy Act; provisions related to energy HR 4024: North America Natural Gas Security and Consumer Protection Act; provisions related to energy HR 4025: Keep American Natural Gas Here Act; provisions related to energy HR 4056: Science and Technology Regulatory Relief Act of 2012; provisions related to energy HR 4136: To provide for the development of a plan to increase oil and gas production under oil and gas leases of Federal lands under the jurisdiction of the Secretary of Agriculture, the Secretary of Energy, the Secretary of the Interior, and the Secretary of Defense in conjunction with a drawdown of petroleum reserves from the Strategic Petroleum Reserve; provisions related to energy HR 4211: American Energy First Act; provisions related to energy HR 4239: Surface Transportation Extension Act of 2012; provisions related to energy and taxes HR 4322: To clarify that a State has the sole authority to regulate hydraulic fracturing on Federal land within the boundaries of the State; provisions related to energy S 275: Pipeline Transportation Safety Improvement Act of 2011; provisions related to pipeline safety S 482: Energy Tax Prevention Act of 2011; provisions related to GHG regulations S 511: Boutique Fuel Reduction Act of 2011; provisions related to fuels S 587: Fracturing Responsibility and Awareness of Chemicals Act (FRAC Act); provisions related to fracturing S 1140: Gulf Coast Restoration Act; provisions related to restoration of Gulf of Mexico coastal areas S 1720: Jobs Through Growth Act; provisions related to GHG regulations and air permits S 1863: New Alternative Transportation to Give Americans Solutions Act of 2011; provisions related to revenue and funding S 1932: A bill to require the Secretary of State to act on a permit for the Keystone XL pipeline; provisions related to the Keystone XL pipeline S 1960: Jobs Creation Act; provisions related to revenue and funding S 1971: Comprehensive Assessment of Regulations on the Economy Act of 2011; provisions related to regulations S 2041: A bill to approve the Keystone XL pipeline project and provide for environmental protection and government oversight; provisions related to the Keystone XL pipeline S 2146: Clean Energy Standard Act of 2012; provisions related to natural gas S 2264: Domestic Fuels Act of 2012; provisions related to fuels S AMDT 1537 to S 1813: Moving Ahead for Progress in the 21st Century Act (MAP-21); provisions related to the Keystone XL pipeline S AMDT 1984 to S 2204: Repeal Big Oil Tax Subsidies Act; provisions related to the Keystone XL pipeline Discussions related to Draft Bureau of Land Management Hydraulic Fracturing Rules Discussions related to oil sands and Keystone Pipeline XL approval Discussions related to energy and shale gas development Discussions related to energy access Discussions related to energy and taxes Energy Outlook Briefings
Client expense: $4,170,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Transportation, Dept of (DOT), White House Office
2012 · first_quarter · Health Issues
Issues related to the 510(k) process for medical devices. [Elizabeth Sharp, Elizabeth Kegler, JC Scott] Issues related to the medical device user fee program [Elizabeth Sharp, Elizabeth Kegler, JC Scott] Sen. Orrin Hatch draft BETTER Patient Care Act. To restructure how the FDA regulates certain advanced diagnostics [JC Scott, Duane Wright] H.R 2182/S. 1734 Generating Antibiotic Incentives Now [Duane Wright, Leah Kegler, Elizabeth Sharp, JC Scott] Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. [Elizabeth Sharp, Elizabeth Kegler, JC Scott] Issues related to diagnostics regulation [Elizabeth Sharp, Elizabeth Kegler, JC Scott, Duane Wright] Issues related to the definition of durable for durable medical equipment [Duane Wright] HR 3209 Premarket Predictability Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3203 Novel Device Regulatory Relief Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3230 Keeping America Competitive Through Harmonization Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3205 FDA Renewing Efficiency From Outside Reviewer Management Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3211 Humanitarian Device Reform Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3208 Patients Come First Act of 2011[Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3206 Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011[Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3214 Food and Drug Administration Mission Reform Act of 2011[Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3207 Modernizing Laboratory Test Standards for Patients Act of 2011[Elizabeth Sharp, Elizabeth Kegler, JC Scott, Duane Wright] HR 3204 Guidance Accountability and Transparency Act of 2011[Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3847 Safety of Untested and New Devices Act of 2012 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] HR 3975 a bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 [Elizabeth Sharp, Elizabeth Kegler] HR 4056 Science and Technology Regulatory Relief Act [Elizabeth Sharp, Elizabeth Kegler] S 1700 Medical Device Regulatory Improvement Act[Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 1865 Patient Access to Medical Innovation Act [Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 1943 Novel Device Regulatory Relief Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 1972 Food and Drug Administration Mission Reform Act of 2011 [Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 1995 Medical Device Patient Safety Act[Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 2067 Safe, Transparent, and Efficient Medical Device Act [Elizabeth Sharp, Elizabeth Kegler, JC Scott] S 2113 A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that encourage innovative products to benefit patients and improve public health [Elizabeth Sharp] S 2193 Ensuring Safe Medical Devices for Patients [Elizabeth Sharp, Elizabeth Kegler]
Client expense: $378,488 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
H.R.4056, Science and Technology Regulatory Relief Act of 2012 (provisions related to medical device company inspections) H.R.2086, Medical Debt Responsibility Act of 2011 S.2149, Medical Debt Responsibility Act of 2012 H.R.3847, Safety of Untested and New Devices (SOUND) Act of 2012 Issues related to the the reauthorization of the Medical Device User Fee and Modernization Act and the Prescription Drug User Fee Act Issues related to medical debt relief and medical loss ratios Issues related to the implementation of health exchanges under the Affordable Care Act Issues related to summary benefits coverage Issues related to healthcare-acquired infections Issues related to the FDA Sentinel Initiative
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
2012 · first_quarter · Health Issues
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act H.R. 3847- Safety of Untested and New Devices Act of 2012 H.R. 3975- A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007 H.R. 4056- Science and Technology Regulatory Relief Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes. S. 2067- Safe, Transparent, and Efficient Medical Device Act S.2113- A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve health S. 2193- Ensuring Safe Medical Devices for Patients Discussion drafts on user fee legislation from the Energy and Commerce Committee and the Health, Education, Labor and Pensions Committee
| Republican |
| CA |
| Mary Bono Mack | Republican | CA |
| Susan A. Davis | Democratic | CA |
Client expense: $370,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE